CVS, Aetna 'Deserve Nobel' If Merger Helps Consumers: Prof

Law360 (June 20, 2018, 12:04 AM EDT) -- CVS Health Corp.'s planned $69 billion purchase of the insurance giant Aetna Inc. drew criticism from academics testifying Tuesday before the California Insurance Commission, with a Wharton School management professor calling the industry "full of BS" and saying the companies "deserve the Nobel Prize" if they deliver on the benefits they are claiming.

Professor Lawton Burns warned the commission to be cautious, "if not suspicious" of vertical mergers and the benefits that Aetna and CVS executives have touted in support of the deal — particularly with regards to CVS pharmacy's retail clinics, which are not primary care and usually are not...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!